Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost SR vs Selective Laser Trabeculoplasty in Open-Angle Glaucoma or Ocular Hypertension
2015-003631-34Phase 3Completed
- Sponsor
- Allergan
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bimatoprost in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Allergan. Primary endpoint: Primary endpoint: change in intraocular pressure at 24 weeks. Started Nov 2016; status: completed.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2015-003631-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003631-34.